From HemOnc.org - A Hematology Oncology Wiki
Jump to: navigation, search

HemOnc.org - A Free Hematology/Oncology Reference

1,581 regimens on HemOnc.org
2,067 variants on HemOnc.org

Created by oncologists as a knowledge base for providers, this site contains reference notes prepared by their peers and allows people to share wisdom and insights from their own clinical experiences for the benefit of all. This shared online notebook will continue to evolve and grow to meet the needs of the community because users such as yourself are able to refine and build upon existing content.

If this is your first time visiting, please go to the tutorial page or just start exploring!

Mobile/tablet version of the main page
How to add a HemOnc.org shortcut to your mobile device's home screen
Quick links to chemotherapy regimens
Solid tumors
Anal cancer Bladder cancer Bone cancer Breast cancer
Central nervous system (CNS) cancer Cervical cancer Colon cancer Esophageal cancer
Gastric cancer Germ cell tumors Head and neck cancer Hepatobiliary cancer
Lung cancer, non-small cell Lung cancer, small cell Melanoma Mesothelioma
Neuroblastoma Neuroendocrine tumors Skin, basal & squamous cancer Ovarian cancer
Pancreatic cancer Penile cancer Prostate cancer Rectal cancer
Renal cancer Sarcoma Testicular cancer Thymoma
Thyroid cancer Unknown primary Uterine cancer
Acute leukemias
Acute lymphocytic leukemia (ALL) Acute myeloid leukemia (AML) Acute promyelocytic leukemia (APL) T-cell acute lymphocytic leukemia (T-ALL/T-LBL)
Transplant conditioning regimens
Myeloproliferative neoplasms and myelodysplastic syndromes
Chronic myelogenous leukemia (CML) Chronic myelomonocytic leukemia (CMML) Essential thrombocythemia (ET) Hypereosinophilic syndrome (HES)
Mast cell diseases Myelodysplastic syndrome Primary & secondary myelofibrosis Polycythemia vera (PV)
Mature B-, T-, and NK-cell neoplasms
Adult T-cell leukemia-lymphoma (ATLL) Anaplastic large cell lymphoma (ALCL) Burkitt lymphoma (BL) or Burkitt-like lymphoma Chronic lymphocytic leukemia (CLL/SLL)
CNS lymphoma Cutaneous T-cell lymphoma (CTCL) Diffuse large B-cell lymphoma (DLBCL) Extranodal NK/T-cell lymphoma, nasal type
Follicular lymphoma (FL) Hairy cell leukemia (HCL) HIV-associated lymphoma Hodgkin lymphoma (HL)
Hodgkin lymphoma, nodular lymphocyte-predominant (NLP-HL) Large granular lymphocytic (LGL) leukemia Light-chain (AL) amyloidosis Mantle cell lymphoma (MCL)
Marginal zone lymphoma (MZL) Mediastinal gray-zone lymphoma (MGZL) Multiple myeloma (MM) NK/T-cell lymphoma
Peripheral T-cell Lymphoma (PTCL) Primary mediastinal B-cell lymphoma (PMBL) Transformed lymphoma (TL) Transplant conditioning regimens
Waldenström macroglobulinemia (WM/LPL)
Other hematology
Aplastic anemia Autoimmune thrombocytopenic purpura (ITP) Castleman’s disease Coagulopathies
Hemophagocytic lymphohistiocytosis (HLH) Histiocytoses Paroxysmal nocturnal hemoglobinuria (PNH) Thrombotic thrombocytopenic purpura (TTP)
Venous thromboembolism (VTE)
Browse our complete index of pages

Any information that one feels would be helpful to other oncology providers is welcome. Visit how to contribute for more details. Priorities of this project include:

  1. Creating a database of chemotherapy agents and other medications.
  2. Creating a database of chemotherapy regimens and references to primary literature (PubMed and direct links to the abstracts/full articles).
  3. Sample order sets and examples of supportive medications used with treatment regimens
  4. Aggregating useful links to existing resources by disease, such as information about prognosis, clinical calculators, staging, and patient resources.

Additional possibilities for this project may include:

  1. Creating summaries of pivotal clinical trials
  2. Establishing homepages for ongoing clinical trials that contain information and sites of participation
  3. Checklists for common clinical scenarios/diseases
  4. Creating checklists that can be used for patients starting therapy with particular regimens, such as laboratory & imaging (e.g. echocardiogram, PFTs) parameters to monitor and informed consent/discussion of side effects

The field of hematology/oncology is ever-changing, and our hope is that other people will be interested in contributing to make it an increasingly more useful resource. The rapidly evolving nature of the practice demands a more dynamic medium than existing resources can provide and would benefit from being able to be updated in real-time from virtually any computer with internet access. We believe that the familiar format of a Wiki, made popular by sites such as Wikipedia, will significantly help ease-of-use and navigation.

If you would like to contribute, please create an account in the upper right corner, and send a message to contact@hemonc.org so that your account can be set up with the necessary rights. Due to the sensitive nature of the information contained within this site, unverified users will not be allowed to edit articles.